Children’s of Alabama, the University of Alabama at Birmingham (UAB) Department of Pediatrics and Pediatric Surgical Divisions are pleased to present our 2021 Academic Annual Report.
Through innovative research collaborations, education programs and advancements in clinical care, we seek to discover and apply new knowledge to improve the health and well-being of the children of Alabama, the region, and throughout the world.
The unparalleled dedication, world-class expertise and broad diversity of our faculty and staff are strengths reflected in the accomplishments shared in this report. We invite you to review the impact, publications, grant funding and awards that are making a substantial difference and continue to place our programs among the best in the nation.
The National Organization for Rare Disorders designated Children’s of Alabama and UAB Medicine as NORD Rare Disease Centers of Excellence. UAB Medicine and Children’s join 31 medical centers as part of the innovative network seeking to expand access, advance care and enhance research for rare diseases patients in the United States. According to the National Institutes of Health, any disease that affects fewer than 200,000 people in the United States is considered rare. There are 7,000 rare diseases, and 25 million to 30 million Americans are estimated to live with a rare disease. People living with rare diseases frequently face challenges finding diagnosis and quality clinical care. Additionally, more than 90 percent of rare diseases lack an approved treatment from the Food and Drug Administration. The designation comes from continued dedication to rare diseases services at UAB and Children’s, including exceptional cytogenetic, molecular and biochemical clinical labs and multidisciplinary clinics such as cleft and craniofacial, muscular dystrophy, Marfan syndrome, Turner syndrome and mitochondrial diseases.